GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (NSE:APLLTD) » Definitions » Market Cap

Alembic Pharmaceuticals (NSE:APLLTD) Market Cap : ₹179,963 Mil (As of Jun. 09, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alembic Pharmaceuticals's share price for the quarter that ended in Mar. 2024 was ₹984.8. Alembic Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 197 Mil. Therefore, Alembic Pharmaceuticals's market cap for the quarter that ended in Mar. 2024 was ₹193,575 Mil.

Alembic Pharmaceuticals's quarterly market cap declined from Sep. 2023 (₹154,194 Mil) to Dec. 2023 (₹149,270 Mil) but then increased from Dec. 2023 (₹149,270 Mil) to Mar. 2024 (₹193,575 Mil).

Alembic Pharmaceuticals's annual market cap declined from Mar. 2022 (₹145,771 Mil) to Mar. 2023 (₹97,564 Mil) but then increased from Mar. 2023 (₹97,564 Mil) to Mar. 2024 (₹193,575 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alembic Pharmaceuticals's Enterprise Value for Today is ₹183,622 Mil.


Alembic Pharmaceuticals Market Cap Historical Data

The historical data trend for Alembic Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Market Cap Chart

Alembic Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100,714.67 189,673.47 145,771.12 97,564.05 193,575.24

Alembic Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97,564.05 125,092.69 154,193.85 149,269.94 193,575.24

Competitive Comparison of Alembic Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alembic Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's Market Cap falls into.



Alembic Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Alembic Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹984.8*196.563
=₹193,575

Alembic Pharmaceuticals's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹984.8*196.563
=₹193,575

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alembic Pharmaceuticals  (NSE:APLLTD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Alembic Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals (NSE:APLLTD) Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (NSE:APLLTD) Headlines

No Headlines